Margherita Bellucci Francesco Germano Stefano Grisanti Chiara Castellano Francesco Tazza Emanuela Maria Mobilia Davide Visigalli Giovanni Novi Federico Massa Silvia Rossi Paolo Durando Corrado Cabona Angelo Schenone Diego Franciotta Luana Benedetti
10.3389/fimmu.2022.894872
Front Immunol
2022 Jul 18;13:894872.
covid-19 vaccine guillain–barrè syndrome autoimmune diseases case report ganglioside antibodies
CC BY
https://pubmed.ncbi.nlm.nih.gov/35924236/
COVID-19 Vaccines / adverse effects COVID-19 / complications Guillain-Barre Syndrome / diagnosis Guillain-Barre Syndrome / etiology
COVID-19 Vaccines / adverse effects COVID-19 / complications Guillain-Barre Syndrome / diagnosis Guillain-Barre Syndrome / etiology Case Reports Research Support, Non-U.S. Gov't Autoantibodies Gangliosides Humans Immunoglobulin M / therapeutic use Immunoglobulins, Intravenous / therapeutic use Male Middle Aged SARS-CoV-2 Autoantibodies COVID-19 Vaccines Gangliosides Immunoglobulin M Immunoglobulins, Intravenous
PMC9339669
35924236
Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS
2022